_1777294237270_124456903.png&w=64&q=75){kind=small}
Ebola Vaccine Trials Begin in DRC
Clinical trials for an Ebola vaccine have begun in the Democratic Republic of the Congo, involving 20,000 volunteers to assess the vaccine's effectiveness against the current Bundibugyo strain. This step comes as part of efforts to control the outbreak, which is among the deadliest in Ebola history, having resulted in 3,639 deaths and 7,541 infections since May, with 1,823 recoveries. Health efforts are supported by approximately 70,000 doses of the Ervebo vaccine, and these trials are a major attempt to provide effective protection against the most dangerous strains.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)